Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2

MLA

Xie, Yuanchao, et al. “Design and Development of an Oral Remdesivir Derivative VV116 against SARS-CoV-2.” Cell Research, vol. 31, no. 11, Nov. 2021, pp. 1212–14. EBSCOhost, https://doi.org/10.1038/s41422-021-00570-1.

APA

Xie, Y., Yin, W., Zhang, Y., Shang, W., Wang, Z., Luan, X., Tian, G., Aisa, H. A., Xu, Y., Xiao, G., Li, J., Jiang, H., Zhang, S., Zhang, L., Xu, H. E., & Shen, J. (2021). Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2. Cell Research, 31(11), 1212–1214. https://doi.org/10.1038/s41422-021-00570-1

Chicago

Xie, Yuanchao, Wanchao Yin, Yumin Zhang, Weijuan Shang, Zhen Wang, Xiaodong Luan, Guanghui Tian, et al. 2021. “Design and Development of an Oral Remdesivir Derivative VV116 against SARS-CoV-2.” Cell Research 31 (11): 1212–14. doi:10.1038/s41422-021-00570-1.